Risk Management in Executive Levels of Healthcare Organizations: Insights from a Scoping Review (2018).
executive levels
health care
organization risk management
risk analysis
scoping review
Journal
Risk management and healthcare policy
ISSN: 1179-1594
Titre abrégé: Risk Manag Healthc Policy
Pays: England
ID NLM: 101566264
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
09
2019
accepted:
27
02
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
epublish
Résumé
This study attempted to present a framework and appropriate techniques for implementing risk management (RM) in executive levels of healthcare organizations (HCOs) and grasping new future research opportunities in this field. A scoping review was conducted of all English language studies, from January 2000 to October 2018 in the main bibliographic databases. Review selection and characterization were performed by two independent reviewers using pretested forms. Following a keyword search and an assessment of fit for this review, 37 studies were analyzed. Based on the findings and considering the ISO31000 model, a comprehensive yet simple framework of risk management is developed for the executive levels of HCOs. It includes five main phases: establishing the context, risk assessment, risk treatment, monitoring and review, and communication and consultation. A set of tools and techniques were also suggested for use at each phase. Also, the status of risk management in the executive levels of HCOs was determined based on the proposed framework. The framework can be used as a training tool to guide in effective risk assessment as well as a tool to assess non-clinical risks of healthcare organizations. Managers of healthcare organizations who seek to ensure high quality should use a range of risk management methods and tools in their organizations, based on their need, and not assume that each tool is comprehensive.
Sections du résumé
BACKGROUND
BACKGROUND
This study attempted to present a framework and appropriate techniques for implementing risk management (RM) in executive levels of healthcare organizations (HCOs) and grasping new future research opportunities in this field.
METHODS
METHODS
A scoping review was conducted of all English language studies, from January 2000 to October 2018 in the main bibliographic databases. Review selection and characterization were performed by two independent reviewers using pretested forms.
RESULTS
RESULTS
Following a keyword search and an assessment of fit for this review, 37 studies were analyzed. Based on the findings and considering the ISO31000 model, a comprehensive yet simple framework of risk management is developed for the executive levels of HCOs. It includes five main phases: establishing the context, risk assessment, risk treatment, monitoring and review, and communication and consultation. A set of tools and techniques were also suggested for use at each phase. Also, the status of risk management in the executive levels of HCOs was determined based on the proposed framework.
CONCLUSION
CONCLUSIONS
The framework can be used as a training tool to guide in effective risk assessment as well as a tool to assess non-clinical risks of healthcare organizations. Managers of healthcare organizations who seek to ensure high quality should use a range of risk management methods and tools in their organizations, based on their need, and not assume that each tool is comprehensive.
Identifiants
pubmed: 32256134
doi: 10.2147/RMHP.S231712
pii: 231712
pmc: PMC7090183
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
215-243Informations de copyright
© 2020 Ferdosi et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Healthc Risk Manag. 2016;35(3):31-7
pubmed: 26789746
Int J Qual Health Care. 2009 Dec;21(6):427-32
pubmed: 19828551
BMC Health Serv Res. 2014 Jan 27;14:41
pubmed: 24467813
Wien Klin Wochenschr. 2015 Jan;127(1-2):1-11
pubmed: 25392253
Int Health. 2017 Jul 1;9(4):252-262
pubmed: 28541518
Int J Qual Health Care. 2018 Apr 1;30(3):227-233
pubmed: 29346654
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Int J Health Care Qual Assur. 2016 May 9;29(4):425-40
pubmed: 27142951
Int J Risk Saf Med. 2015;27(2):67-76
pubmed: 26410009
Neurosurg Clin N Am. 2015 Apr;26(2):177-87, viii
pubmed: 25771273
Qual Saf Health Care. 2005 Apr;14(2):93-8
pubmed: 15805453
BMJ Qual Saf. 2011 Aug;20(8):698-703
pubmed: 21385890
Int J Risk Saf Med. 2014;26(4):199-211
pubmed: 25420762
J Healthc Risk Manag. 2014;33(4):5-14
pubmed: 24756824
Drug Saf. 2009;32(8):663-73
pubmed: 19591531
J Patient Saf. 2013 Sep;9(3):154-9
pubmed: 23965838
J Pharm Policy Pract. 2015 Feb 28;8(1):9
pubmed: 25838919
World J Emerg Med. 2016;7(2):97-105
pubmed: 27313803
Int J Qual Health Care. 2010 Oct;22(5):386-95
pubmed: 20699233
Rev Med Chil. 2014 Feb;142(2):153-60
pubmed: 24953102
Physician Exec. 2014 Jul-Aug;40(4):28-32
pubmed: 25188976
Ergonomics. 2018 Aug;61(8):1046-1064
pubmed: 29394872
Ergonomics. 2010 Jul;53(7):829-47
pubmed: 20582765
Risk Anal. 2010 Dec;30(12):1857-71
pubmed: 20723148
World Hosp Health Serv. 2008;44(4):21-3
pubmed: 19370832
J Med Econ. 2012;15(2):285-92
pubmed: 22149533
Risk Anal. 2014 Aug;34(8):1469-81
pubmed: 24341726
PLoS One. 2015 Nov 30;10(11):e0142389
pubmed: 26619143
Int J Health Care Qual Assur. 2015;28(8):791-811
pubmed: 26440483
Ergonomics. 2018 Jan;61(1):104-121
pubmed: 28498024
Int J Prev Med. 2018 Jan 29;9:7
pubmed: 29441184
Drug Dev Ind Pharm. 2014 Jan;40(1):46-60
pubmed: 23216278